Humoral and cellular immune responses to the GB virus C hepatitis G virus envelope 2 protein

被引:0
作者
Lazdina, U
Hultgren, C
Chen, M
Fischler, B
Weiland, O
Mushahwar, IK
Sällberg, M
机构
[1] Huddinge Hosp, Karolinska Inst, Div Clin Virol, S-14186 Huddinge, Sweden
[2] Huddinge Hosp, Karolinska Inst, Div Basci Oral Sci, S-14186 Huddinge, Sweden
[3] Huddinge Hosp, Karolinska Inst, Dept Pediat, S-14186 Huddinge, Sweden
[4] Huddinge Hosp, Karolinska Inst, Div Infect Dis, S-14186 Huddinge, Sweden
[5] Abbott Labs, Virus Discovery Grp, Chicago, IL USA
关键词
immune responses; hepatitis G virus; E2; antibodies;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Immune responses to two recombinant envelope 2 (E2) proteins, representing genotypes 1 and 2 of the GB virus C, or the hepatitis G virus (GBV-C/HGV), were studied in mice and in 48 individuals with, or without, chronic, or past GBV-C/HGV infection. Immunised mice developed E2-specific antibodies (mean titres, 1:1,167 to 1:9,360), recognising linear antigenic regions and proliferative and IL-2, IL-6 and gamma IFN cytokine responses regardless of the viral genotype. Individuals with past GBV-C infection had E2 antibody titres from 1:1,500 to 1:7,500 that did not recognise the E. coli derived E2 protein or linear antigenic regions. Proliferative E2-specific responses were detected in peripheral blood mononuclear cells from 6/22 (27%) persons with, and in none without GBV-C markers (P < 0.05). Thus, E2-specific immune responses are mainly crossreactive between different variants of GBV-C/HGV, although proliferative responses appear to be rare. J. Med. Virol. 62:334-344, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:334 / 344
页数:11
相关论文
共 32 条
[1]   Coexisting members of HIV-1 p17 gene quasispecies represent proteins with distinct antigenicity and immunogenicity [J].
Birk, M ;
Flock, JI ;
Sönnerborg, A ;
Sallberg, M .
AIDS, 1998, 12 (15) :1973-1981
[2]   Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors [J].
Blair, CS ;
Davidson, F ;
Lycett, C ;
McDonald, DM ;
Haydon, GH ;
Yap, PL ;
Hayes, PC ;
Simmonds, P ;
Gillon, J .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1779-1782
[3]   Detection of hepatitis G virus (GB virus C) RNA in human saliva [J].
Chen, M ;
Sonnerborg, A ;
Johansson, B ;
Sallberg, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (04) :973-975
[4]   Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein [J].
Chen, M ;
Sällberg, M ;
Sönnerborg, A ;
Jin, L ;
Birkett, A ;
Peterson, D ;
Weiland, O ;
Milich, DR .
HEPATOLOGY, 1998, 28 (01) :219-224
[5]   POSSIBLE MECHANISM INVOLVING T-LYMPHOCYTE RESPONSE TO NONSTRUCTURAL PROTEIN-3 IN VIRAL CLEARANCE IN ACUTE HEPATITIS-C VIRUS-INFECTION [J].
DIEPOLDER, HM ;
ZACHOVAL, R ;
HOFFMANN, RM ;
WIERENGA, EA ;
SANTANTONIO, T ;
JUNG, MC ;
EICHENLAUB, D ;
PAPE, GR .
LANCET, 1995, 346 (8981) :1006-1007
[6]   An ELISA for detection of antibodies to the E2 protein of GB virus C [J].
Dille, BJ ;
Surowy, TK ;
Gutierrez, RA ;
Coleman, PF ;
Knigge, MF ;
Carrick, RJ ;
Aach, RD ;
Hollinger, FB ;
Stevens, CE ;
Barbosa, LH ;
Nemo, GJ ;
Mosley, JW ;
Dawson, GJ ;
Mushahwar, IK .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) :458-461
[7]   Genetic evidence for mother-to-infant transmission of hepatitis G virus [J].
Fischler, B ;
Lara, C ;
Chen, M ;
Sonnerborg, A ;
Nemeth, A ;
Sallberg, M .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :281-285
[8]   Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products [J].
Halasz, R ;
Barkholt, L ;
Lara, C ;
Hultgren, C ;
Ando, Y ;
Broomé, U ;
Fischler, B ;
Nemeth, A ;
Ericzon, BG ;
Sönnerborg, A ;
Sällberg, M .
GUT, 1999, 44 (02) :274-278
[9]  
Hollingsworth RC, 1998, J MED VIROL, V56, P321, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt
[10]  
321::AID-JMV6&gt